| HOME >> BIOLOGY >> TECHNOLOGY |
WALTHAM, Mass., May 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI) announced today that Lewis H. Bender, Chief Executive Officer, will present at the Rodman and Renshaw 5th Annual Global Healthcare Conference on Monday May 19, 2008, at 10:00 a.m. CEST (4:00 a.m. EDT). The conference will be held at Le Meridien Beach Plaza Hotel, Monte Carlo, Monaco.
A live audio webcast of the presentation will be available on the Investors section of the Company's website, http://www.ilgenetics.com. A replay of the presentation will be available on the Interleukin Genetics website for 14 days following the presentation.
About Interleukin Genetics
Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused
personalized health company that develops preventive consumer products and
genetic tests for sale to the emerging personalized health market. Focused
on the future of health and medicine, Interleukin uses its leading genetics
research and scientific capabilities to develop and test innovative
preventive and therapeutic products. Interleukin currently offers an array
of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and
Venastat(R) which are sold at the nation's largest food, drug and mass
retailers, and has commercialized genetic tests for periodontal disease
risk assessment, cardiovascular risk assessment, and general nutrition
assessment. Interleukin is headquartered in Waltham, MA. For more
information about Interle
'/>"/>
| SOURCE Interleukin Genetics, Inc. Copyright©2008 PR Newswire. All rights reserved |